Product Information
ZONISAMIDE 100 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.1062 per EA under NDC 69097086107. Its NADAC has been published 530 times since Aug 10, 2016.
FDA first approved this application on May 31, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Cipla USA Inc.NDC
69097086107
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ZONISAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077869FDA Approved
5/31/2006
TE Code
AB
On Market Since
7/13/2016
Pharmacological Classes
Price Statistics
The NADAC for ZONISAMIDE 100 MG CAPSULE has been published 530 times since Aug 10, 2016, and over the history we have for it it has declined 28.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1062 per EA |
|---|---|
| All-time high | $0.1832 (Aug 11, 2021) |
| All-time low | $0.0857 (Nov 20, 2024) |
| 52-week high | $0.1087 |
| 52-week low | $0.1052 |
| Median price | $0.1348 |
| Average price | $0.1330 |
| Largest weekly change | +31.0% (Oct 20, 2021) |
| Weeks tracked | 530 |
| Tracking since | Aug 10, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the zonisamide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
zonisamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZONISAMIDE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ZONISAMIDE 100 MG CAPSULE, manufactured by Cipla USA Inc., is $0.1062 per EA (NDC 69097086107), effective Sep 30, 2026.
How has the price of ZONISAMIDE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ZONISAMIDE 100 MG CAPSULE has declined 28.0%. It has been tracked across 530 weekly CMS publications since Aug 10, 2016.
What are the highest and lowest recorded NADAC prices for ZONISAMIDE 100 MG CAPSULE?
Since Aug 10, 2016, the NADAC for ZONISAMIDE 100 MG CAPSULE has ranged from a low of $0.0857 (Nov 20, 2024) to a high of $0.1832 (Aug 11, 2021), with a median of $0.1348 per EA.
Are there cheaper alternatives to ZONISAMIDE 100 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ZONISAMIDE 100 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZONISAMIDE 100 MG CAPSULE?
ZONISAMIDE 100 MG CAPSULE (NDC 69097086107) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.